Play

Myc, ras, BRCA…these are all shorthand for common cancer mutations, with a new study saying that’s how cancers should be identified rather than which organ or system they’re found in, since not knowing the mutations may delay proper treatment. Kimmel …

Should cancers be named according to which mutations they carry? Elizabeth Tracey reports Read more »

Play

All cancers carry mutations, and these should direct how they are named, NOT where they are located. That’s the stance of a new study finding that treatments that are targeted to the actual mutations a cancer carries rely on identifying …

Should cancers be named differently? Elizabeth Tracey reports Read more »

Play

More cancers were diagnosed in 2023 than in the previous year, the American Cancer Society says, but cancer deaths are not rising at the same rate. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says as our …

Reducing cancer rates will rely on a more complete understanding of what causes the disease, Elizabeth Tracey reports Read more »

Play

While overall cancer deaths are continuing their decline, there are three that are still problematic, the most recent data from the American Cancer Society demonstrates. Johns Hopkins Kimmel Cancer Center director William Nelson names them. Nelson: The ones to watch …

Deaths from certain cancers continue to rise, Elizabeth Tracey reports Read more »

Play

The annual analysis of the American Cancer Society reports that while the overall number of new cancers diagnosed is higher than last year, deaths from cancers are not rising along with the new cases. Sidney Kimmel Cancer center director William …

The American Cancer Society reports many new cancers but not rising deaths, Elizabeth Tracey reports Read more »

Play

Employing treatments like chemotherapy shortly before someone dies is not only ineffective, it can reduce quality of life and someone’s ability to interact with loved ones. Now a new study examines how often immunotherapy is utilized within a month of …

How often is immunotherapy for cancer used shortly before death? Elizabeth Tracey reports Read more »

Play

Diabetes drugs known as GLP1 receptor agonists are much in the news for weight loss. Now a new study finds that when people with diabetes take them, their risk of colorectal cancer is reduced. Kimmel Cancer Center director William Nelson …

Can a diabetes drug reduce the risk for colorectal cancer? Elizabeth Tracey reports Read more »